1,827
Views
18
CrossRef citations to date
0
Altmetric
PERSPECTIVES

Venous Admixture in COPD: Pathophysiology and Therapeutic Approaches

&
Pages 376-381 | Published online: 02 Jul 2009

REFERENCES

  • Cooper C B. Determining the role of exercise in patients with chronic pulmonary disease. Med Sci Sports Exerc 1995; 27: 147–157
  • Astrand P-O, Rodahl K. Textbook of work physiology. McGraw-Hill. 1970
  • West J B. Ventilationblood flow and gas exchange. 4th ed. Blackwell Scientific Publications, Oxford 1985
  • Wagner P D. Ventilation/perfusion relationships. Clin Physiol 1981; 1: 437–451
  • Cooper C B, Storer T W. Exercise Testing and Interpretation: A Practical Approach. Cambridge University Press, New York 2001
  • Wagner P D. New ideas on limitations to VO2 max. Exerc Sport Sci Rev 2000; 28: 10–14
  • Spiro S G, Hahn H L, Edwards R H, et al. An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax 1975; 30: 415–425
  • Marchetti N, Panetta N, Criner G. The effect of lung hyperinflation in COPD on cardiac function. Proc Am Thorac Soc 2008; 177: A782
  • Montes de Oca M, Rassulo J, Celli B R. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154: 1284–1289
  • Wagner P D. Diffusive resistance to O2 transport in muscle. Acta Physiol Scand 2000; 168: 609–614
  • Severinghaus J W. Simple, accurate equations for human blood O2 dissociation computations. J Appl Physiol 1979; 46: 599–602
  • John M, Lange A, Hoernig S, et al. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006; 111: 365–370
  • Cote C, Zilberberg M D, Mody S H, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur RespirJ 2007; 29: 923–929
  • Moore G E, Parsons D B, Stray-Gundersen J, et al. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis 1993; 22: 277–287
  • Cooper C B. Exercise in chronic pulmonary disease: aerobic exercise prescription. Med Sci Sports Exerc 2001; 33: S671–679
  • Fabbri L, Pauwels R A, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary updated 2003. COPD 2004; 1: 105–141, discussion 103–104
  • Mannino D M, Homa D M, Akinbami L J, et al. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002; 51: 1–16
  • Cooper C B. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006; 119: 21–31
  • Casaburi R, Petty T L. Principles and practice of pulmonary rehabilitation. WB Saunders Company, Philadelphia 1993
  • Celli B, Zu Wallack R, Wang S, et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003; 124: 1743–1748
  • O'Donnell D E, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur RespirJ 2004; 23: 832–840
  • O'Donnell D E, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur RespirJ 2004; 24: 86–94
  • Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390–1413
  • Casaburi R, Patessio A, Ioli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 9–18
  • Casaburi R, Porszasz J, Burns M R, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 1541–1551
  • Cooper C B. Long-term oxygen therapy. Principles and practice of pulmonary rehabilitation, R Casaburi, T L Petty. WB Saunders Company, Philadelphia 1993
  • Emtner M, Porszasz J, Burns M, et al. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168: 1034–1042
  • Markovitz G H, Cooper C B. Exercise and interstitial lung disease. Curr Opin Pulm Med 1998; 4: 272–280
  • Ekblom B T. Blood boosting and sport. Baillieres Best Pract Res Clin Endocrinol Metab 2000; 14: 89–98
  • Levine B D, Stray-Gundersen J. “Living high-training low”: effect of moderate-altitude acclimatization with low-altitude training on performance. J Appl Physiol 1997; 83: 102–112
  • Gaudard A, Varlet-Marie E, Bressolle F, et al. Drugs for increasing oxygen and their potential use in doping: a review. Sports Med 2003; 33: 187–212
  • Brittinger W D, Twittenhoff W D, Schwarzbeck A, et al. Haemodynamic effects of A-V shunts and their clinical significance. Proc Eur Dial Transplant Assoc 1972; 9: 642–649
  • Cooper C, Galindo J, Posadas R, et al. Improved exercise performance with supplemental oxygen predicts a beneficial response to therapeutic arterio-venous fistula in patients with severe COPD. Chest 2007; 132: 453S